It stimulates mammary carcinoma hyper proliferation by inducing phosphorylation and, presumably, activation of c-Jun, the preferred dimer partner of Fra-2 (Eferl and Wagner 2003; Foletta 1996). Here, FOSL2 is linked to breast carcinoma.